Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trifarotene 50 µg/g cream in acne vulgaris
NCT02189629Phase 3Completed
- Sponsor
- Galderma
- Start
- Feb 2015
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of trifarotene in acne vulgaris, sponsored by Galderma. Started Feb 2015; status: completed.
02
Drugs
trifarotene
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT02189629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02189629.